Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017

키워드

참고문헌 (39)

1. Turner RC, "Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)", JAMA, 281, pp.2005~2012 (1999), UK Prospective Diabetes Study (UKPDS) Group
2. Ohkubo Y, "Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study", Diabetes Res Clin Pract, 28, pp.103~117 (1995)
3. Weng J, "Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicenter randomised parallel-group trial", Lancet, 371, pp.1753~1760 (2008)
4. 류혜진, "Safety and Efficacy of Modern Insulin Analogues", Diabetes and Metabolism Journal, 37(3), pp.181~189 (2013), 대한당뇨병학회[DOI]
5. Hwang YC, "The glycemic efficacies of insulin analogue regimens according to baseline glycemic status in Korean patients with type 2 diabetes:sub-analysis from the A(1)chieve((R)) study", Int J Clin Pract, 68, pp.1338~1344 (2014)
6. 양여리, "Reduction of Sulfonylurea with the Initiation of Basal Insulin in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Undergoing Long-Term Sulfonylurea-Based Treatment", Diabetes and Metabolism Journal, 40(6), pp.454~462 (2016), 대한당뇨병학회[DOI]
7. 김상수, "Insulin Initiation in Insulin-Naïve Korean Type 2 Diabetic Patients Inadequately Controlled on Oral Antidiabetic Drugs in Real-World Practice: The Modality of Insulin Treatment Evaluation Study", Diabetes and Metabolism Journal, 39(6), pp.481~488 (2015), 대한당뇨병학회[DOI]
8. 최성희, "Comparison of Antidiabetic Regimens in Patients with Type 2 Diabetes Uncontrolled by Combination Therapy of Sulfonylurea and Metformin: Results of the MOHAS Disease Registry in Korea", Diabetes and Metabolism Journal, 41(3), pp.170~178 (2017), 대한당뇨병학회[DOI]
9. Malmberg K, "Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study", Circulation, 99, pp.2626~2632 (1999)
10. 용윤미, "Intensive Individualized Reinforcement Education Is Important for the Prevention of Hypoglycemia in Patients with Type 2 Diabetes", Diabetes and Metabolism Journal, 39(2), pp.154~163 (2015), 대한당뇨병학회
11. Horvath K, "Long-acting insulin analogues versus NPH insulin (human isophane insulin)for type 2 diabetes mellitus", Cochrane Database Syst Rev, (2), pp.CD005613~ (2007)
12. Holman RR, "Addition of biphasic, prandial, or basal insulin to oral therapy in type 2diabetes", N Engl J Med, 357, pp.1716~1730 (2007)
13. Holman RR, "Three-year efficacy of complex insulin regimens in type 2 diabetes", N Engl J Med, 361, pp.1736~1747 (2009)
14. Giugliano D, "Efficacy of insulin analogs in achieving the hemoglobin A1c target of <7% in type 2 diabetes:meta-analysis of randomized controlled trials", Diabetes Care, 34, pp.510~517 (2011)
15. Yki-Jarvinen H, "Effects of adding linagliptin to basal insulin regimen for inadequately controlled type 2 diabetes: a ≥52-week randomized, double-blind study", Diabetes Care, 36, pp.3875~3881 (2013)
16. Monnier L, "Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients:variations with increasing levels of HbA(1c)", Diabetes Care, 26, pp.881~885 (2003)
17. Aschner P, "Insulin glargine compared with premixed insulin for management of insulin-naïve type 2 diabetes patients uncontrolled on oral antidiabetic drugs: the open-label, randomized GALAPAGOS study", J Diabetes Complications, 29, pp.838~845 (2015)
18. Lee YH, "Predictive characteristics of patients achieving glycaemic control with insulin after sulfonylurea failure", Int J Clin Pract, 65, pp.1076~1084 (2011)
19. Douek IF, "Continuing metformin when starting insulin in patients with type 2 diabetes: a double-blind randomized placebo-controlled trial", Diabet Med, 22, pp.634~640 (2005)
20. 석지혜, "Current Status of Prescription in Type 2 Diabetic Patients from General Hospitals in Busan", Diabetes and Metabolism Journal, 38(3), pp.230~239 (2014), 대한당뇨병학회[DOI]
21. Fonseca V, "An analysis of early insulin glargine added to metformin with or without sulfonylurea:impact on glycaemic control and hypoglycaemia", Diabetes Obes Metab, 13, pp.814~822 (2011)
22. Park CY, "Comparison between the therapeutic effect of metformin, glimepiride and their combination as an add-on treatment to insulin glargine in uncontrolled patients with type 2 diabetes", PLoS One, 9, pp.e87799~ (2014)
23. Charbonnel B, "Pioglitazone use in combination with insulin in the prospective pioglitazone clinical trial in macrovascular events study (PROactive19)", J Clin Endocrinol Metab, 95, pp.2163~2171 (2010)
24. Clar C, "Adding pioglitazone to insulin containing regimens in type 2 diabetes: systematic review and meta-analysis", PLoS One, 4, pp.e6112~ (2009)
25. Hong ES, "Comparison between sitagliptin as add-on therapy to insulin and insulin dose-increase therapy in uncontrolled Korean type 2 diabetes:CSI study", Diabetes Obes Metab, 14, pp.795~802 (2012)
26. Kothny W, "Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus", Diabetes Obes Metab, 15, pp.252~257 (2013)
27. Devineni D, "Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin", Diabetes Obes Metab, 14, pp.539~545 (2012)
28. Rosenstock J, "Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes", Diabetes Care, 37, pp.1815~1823 (2014)
29. Wilding JP, "Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial", Ann Intern Med, 156, pp.405~415 (2012)
30. Min SH, "Comparison between SGLT2 inhibitors and DPP4 inhibitors added to insulin therapy in type 2 diabetes: a systematic review with indirect comparison meta-analysis", Diabetes Metab Res Rev, 33, pp.e2818~ (2017)
31. 고승현, "Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association", Diabetes and Metabolism Journal, 41(5), pp.337~348 (2017), 대한당뇨병학회[DOI]
32. Inzucchi SE, "Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes", Diabetes Care, 38, pp.140~149 (2015)
33. Diamant M, "Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes", Diabetes Care, 37, pp.2763~2773 (2014)
34. Eng C, "Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2diabetes: a systematic review and meta-analysis", Lancet, 384, pp.2228~2234 (2014)
35. 윤건호, "Exenatide versus Insulin Lispro Added to Basal Insulin in a Subgroup of Korean Patients with Type 2 Diabetes Mellitus", Diabetes and Metabolism Journal, 41(1), pp.69~74 (2017), 대한당뇨병학회[DOI]
36. Raccah D, "When basal insulin therapy in type 2 diabetes mellitus is not enough:what next?", Diabetes Metab Res Rev, 23, pp.257~264 (2007)
37. Giugliano D, "Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes:a systematic review and meta-analysis of randomized controlled trials", Endocrine, 51, pp.417~428 (2016)
38. Dieuzeide G, "Safety and effectiveness of biphasic insulin aspart 30 in people with type 2 diabetes switching from basal-bolus insulin regimens in the A1chieve study", Prim Care Diabetes, 8, pp.111~117 (2014)
39. Mathieu C, "Switching from premixed insulin to basal-bolus insulin glargine plus rapid-acting insulin: the ATLANTIC study", Acta Clin Belg, 68, pp.28~33 (2013)

관련 논문AI추천